Red Flags Detected
- Delisting (new) — Company received Nasdaq deficiency notice for failing to maintain minimum $2.5M stockholders' equity requirement, now at risk of delisting.
Transcode Therapeutics receives Nasdaq delisting warning over equity deficiency
Filed May 22, 2026 · Period ending May 19, 2026 · ~1 min read
4 material changes detected in this filing.
Create a free account to read the full summary — it takes 30 seconds.
Partner
Trade RNAZ commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
View original filing on SEC.gov
Generated by AI · May 24, 2026 1:05 PM